affimed.com (AFMD) Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization
This chart of Affimed (AFMD) share prices demonstrates an EV/EBITDA multiple of . The business relies on developing health-enhancing products while operating within a stable geopolitical environment. However, risks stem from costly research and competition for market share with industry behemoths. To optimize processes, Affimed (AFMD) delegates production and testing to external contractors, focusing instead on innovations in cancer therapy.
affimed.com - analytical breakdowns and key metrics (AFMD)
- current price and projected stock value:
- market capitalization details:
- book value of equity indicators:
- debt level and financial liquidity data:
- business earnings and investment ratios data:
AFMD - Profit After Tax|Projected Future Earnings Affimed|AFMD - Business Payback Period|Future Price to Earnings Affimed N.V.|AFMD - Price/Earnings to Growth Multiple|EV/EBITDA Multiple AFMD|AFMD - Profit before interest, taxes and amortization|Net earnings per share (EPS TTM) Affimed|AFMD - Earnings per share for the last 12 months|Quarterly EPS earnings growth affimed.com|AFMD - Earnings growth in current year|Earnings growth forecast for next year Affimed
Initial company analysis:Affimed Therapeutics AFMD
To select high-quality assets, an investor must compare the total business value with its operational efficiency. This indicator assesses the ratio of enterprise value to earnings before interest, taxes, depreciation, and amortization, determining the capital payback period. For Affimed (AFMD), with its high-tech laboratories and rigorous antibody production cycle, the EV/EBITDA ratio—accounting for operating profit and depreciation on GURU.Markets—clearly demonstrates the extent to which the company is overvalued or undervalued.
Competitors of Affimed
EV/EBITDA Multiple ARGX (Argenx)|Total Company Value to Operating Income Before Depreciation Ratio BioNTech Pharma (BNTX)|ABVX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|admabiologics.com (ADMA) - Enterprise Value to EBITDA Ratio|Protagonist (PTGX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Immunovant Inc|Enterprise Value to EBITDA Ratio KNSA|EV/EBITDA Multiple Grifols Biemat|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Adaptive Biotechnologies (ADPT)|celldex.com - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple AUPH (Aurinia Pharmaceuticals Inc.)|BioCryst Pharmaceuticals, Inc. (BCRX) - Company Value to EBITDA|Vera Pharma - EV/EBITDA Multiple|DNTH - EV/EBITDA Multiple|PHVS: EV/EBITDA Multiple|Company Value to Operating Income Before Depreciation Ratio ABCL (AbCellera)|TRML (Tourmaline Bio) - EV/EBITDA Multiple|Precigen Inc - Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple PHAR|Total Company Value to Operating Income Before Depreciation Ratio Nektar Corp|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Upstream Bio Inc UPB|ZBIO - Enterprise Value to EBITDA Ratio|Immunome - EV/EBITDA Multiple|Company Value to EBITDA Gossamer Bio Inc|KALV: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation SEPN|PVLA (Pieris Pharmaceuticals) - EV/EBITDA Multiple|EV/EBITDA Multiple savarapharma.com|EV/EBITDA Multiple RIGL|ANAB: Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Astria Pharma ATXS|ENGN - Enterprise Value to EBITDA Ratio|RAPT Therapeutics - EV/EBITDA Multiple|JBIO (Aerovate Therapeutics Inc) - Enterprise Value to Operating Income Before Depreciation|Aclaris Therapeutics, Inc. (ACRS) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio KYTX (Kyverna Therapeutics Inc.)|TLSA (Tiziana Life Sciences PLC) - EV/EBITDA Multiple|CABA: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple VTYX|EV/EBITDA Multiple theratech.com (THTX)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Avalo Therapeutics AVTX|Business Value to Operating Income Before Depreciation ELDN|AGEN - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Climb Bio, Inc (CLYM) - Enterprise Value to EBITDA Ratio|ZURA: EV/EBITDA Multiple|atyrpharma.com (ATYR) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio ADAG|IMA: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple STTK|Total Company Value to Operating Income Before Depreciation Ratio equilliumbio.com|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Connect Biopharma Holdings Limited CNTB|IMUX - Enterprise Value to EBITDA Ratio|ATRA - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|InflaRx N.V. (IFRX) - Enterprise Value to EBITDA Ratio|XFOR (X4 Pharma) - Enterprise Value to EBITDA Ratio|Adicet Bio, Inc. (ACET) - EV/EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Celularity Inc|Enterprise Value to Operating Income Before Depreciation INMB (inmunebio.com)|EV/EBITDA Multiple BRNS|KZR - Company Value to EBITDA|EV/EBITDA Multiple SABS (SAB Biotherapeutics, Inc)|EV/EBITDA Multiple Akari Therapeutics, Plc AKTX|Enlivex Therapeutics, Ltd. - EV/EBITDA Multiple|Company Value to Operating Income Before Depreciation Ratio QTTB|GOVX: EV/EBITDA Multiple|Company Value to Operating Income Before Depreciation Ratio EDSA (Edesa Biotech Inc)|IBIO (iBio Corp) - EV/EBITDA Multiple|Carisma Tx (CARM) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization XTL Biopharmaceuticals (XTLB)|Enterprise Value to EBITDA Ratio boltbio.com BOLT|EV/EBITDA Multiple HCWB (HCW Biologics)|Aptevo Therapeutics, Inc. (APVO) - Company Value to EBITDA|AIM ImmunoTech Inc. - EV/EBITDA Multiple|ADTX (Aditxt) - Enterprise Value to Operating Income Before Depreciation|GRI: EV/EBITDA Multiple|xortx.com (XRTX) - EV/EBITDA Multiple|HIND (Vyome Holdings) - EV/EBITDA Multiple|Revelation Biosciences Inc - Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Indaptus (INDP)|Enterprise Value to EBITDA Ratio BiondVax Pharmaceuticals SCNI|EV/EBITDA Multiple CALI (CalciMedica)|ALLK: Enterprise Value to Operating Income Before Depreciation|HOOK - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio IGMS|ITOS: EV/EBITDA Multiple|Ocean Biomedical Corp - Business Value to Operating Income Before Depreciation|TCBP (TC Biopharm) - EV/EBITDA Multiple|EV/EBITDA Multiple thirdharmonicbio.com
